1_cancer (1)
π Society
Why inequality is passed from one generation to the next

Inequalities in the face of cancer: who are the most vulnerable?

with Gwenn Menvielle, Research Director in Post-Cancer at Inserm and Aurore Loretti, Lecturer at ETHICS Laboratory's Medical Ethics Centre at Université Catholique de Lille
On December 10th, 2024 |
5 min reading time
Gwenn Menvielle
Gwenn Menvielle
Research Director in Post-Cancer at Inserm
Aurore Loretti
Aurore Loretti
Lecturer at ETHICS Laboratory's Medical Ethics Centre at Université Catholique de Lille
Key takeaways
  • Cancers more frequently affect the lower social classes, particularly the deadliest cancers, such as lung and upper aerodigestive tract cancers.
  • This disparity can be explained by the fact that disadvantaged groups are more exposed to risk factors such as smoking and exposure to carcinogenic substances before they become ill.
  • In France, health inequalities tend to worsen as the disease progresses, due to more frequent delays in diagnosis and lower levels of participation in screening campaigns among people from poorer backgrounds.
  • Studies show that these inequalities are more marked among men, particularly if they are isolated, than among women, although inequalities in mortality rates amongst women are increasing.
  • Inequalities also persist after the disease: for example, lung cancer, which is particularly impacted by social factors, leads to increased social inequalities and greater uncertainty when it comes to returning to work.

Through­out the world, the poorer people are, the less healthy they are, and France is no excep­tion. Can­cer, the lead­ing cause of death in France, is a major con­trib­ut­or to the country’s social inequal­it­ies in health, account­ing for 40% among men and 30% among women1. How does social status affect can­cer? Vari­ous stud­ies show that it increases the risk of devel­op­ing these dis­eases, makes the treat­ment pro­cess more dif­fi­cult and con­trib­utes to a decline in qual­ity of life after treatment.

Pre-disease: socially marked risk factors

It’s true that breast can­cer tends to affect more afflu­ent people. But for the major­ity of oth­er can­cers, the incid­ence is much high­er among people from lower social classes. The dead­li­est forms of can­cers (lung and upper aerodi­gest­ive tract) appear to be par­tic­u­larly asso­ci­ated with social deprivation.

How can this be explained? The answer lies essen­tially in the social determ­in­ism of the main risk factors. For example, while tobacco con­sump­tion is unan­im­ously recog­nised as the major risk factor for lung can­cer and one of the two main risk factors, along­side alco­hol, for can­cers of the upper aerodi­gest­ive tract, 2.3 times as many people in the low socio-eco­nom­ic classes smoke daily as those in the high socio-eco­nom­ic classes (the trend is reversed for alco­hol, how­ever: con­sump­tion is 1.3 times high­er in the high socio-eco­nom­ic classes2).

But con­trary to cer­tain pre­con­ceived ideas, this risky con­sump­tion is not always the res­ult of a totally free indi­vidu­al choice. In his book La cigar­ette du pauvre (The Poor Man’s Cigar­ette), Patrick Per­etti-Watel high­lights the early social­ising role of cigar­ettes in dis­ad­vant­aged groups, explain­ing that “pre­cari­ous­ness induces stress, which encour­ages smoking(…). Pre­cari­ous­ness also shortens the time hori­zon, which impacts the abil­ity to put the harm­ful effects of smoking in the long-term into per­spect­ive”. Quit­ting smoking, a major act of pre­ven­tion, is there­fore much more dif­fi­cult for people in pre­cari­ous situations.

Fur­ther­more, while smoking is rightly singled out as a cause of inequal­it­ies, oth­er risk factors with a sig­ni­fic­ant social impact, such as occu­pa­tion­al expos­ure to car­ci­no­gens, should not be over­looked. “Stud­ies indic­ate that the impact of these factors has been much less stud­ied, even though they seem to carry a great deal of weight. Health­care pro­fes­sion­als them­selves are less aware of them,” explains Aurore Loretti.

Des­pite the pro­gress made in recent dec­ades, these expos­ure remains fre­quent in France. The latest sur­vey, Sur­veil­lance médicale des expos­i­tions des salar­iés aux risques pro­fes­sion­nels (Med­ic­al Sur­veil­lance of Employ­ee Expos­ure to Occu­pa­tion­al Risks), car­ried out in 2017, showed that 11% of employ­ees had been exposed to at least one car­ci­no­gen in the last week worked3. Half of these were blue-col­lar workers.

During the illness: an accumulation of inequalities

Inequal­it­ies are then com­poun­ded over the course of treat­ment. “Whatever the loc­a­tion of the can­cer, the lower your socio-eco­nom­ic status, the lower your sur­viv­al rate” con­firms Gwenn Menvielle.

Yet France has a num­ber of advant­ages. Its health­care sys­tem is more effi­cient than many of its European neigh­bours: while the num­ber of can­cer cases in the gen­er­al pop­u­la­tion is high­er (asso­ci­ated with high­er aver­age con­sump­tion of tobacco and alco­hol, and lower vac­cin­a­tion rates against HPV), sur­viv­al rates are bet­ter. Per cap­ita spend­ing on can­cer care is among the highest in Europe, and the pro­por­tion of health­care costs that patients pay is the low­est of all European Uni­on coun­tries4.

One might ima­gine that, with the fin­an­cial bar­ri­er at least par­tially removed, the influ­ence of patients’ mater­i­al cir­cum­stances would be less marked than in neigh­bour­ing coun­tries. But this is not the case. Anoth­er obstacle stands in the way of the most dis­ad­vant­aged people: the need to con­sult a doc­tor in the event of symp­toms or to under­go screen­ing. Sig­ni­fic­ant delays in dia­gnos­is are observed in the least priv­ileged envir­on­ments, and par­ti­cip­a­tion rates in nation­al screen­ing cam­paigns (for breast, cer­vical and colon can­cer) are much lower among the most dis­ad­vant­aged pop­u­la­tions. “Liv­ing in pre­cari­ous con­di­tions can lead people to put pre­ven­tion on the back burn­er, play down their symp­toms and put off seek­ing med­ic­al advice by resort­ing to self-medication. 

But pre­ven­tion policy also plays an import­ant role. While breast can­cer receives a great deal of media cov­er­age, we hear much less about colon can­cer, for example, des­pite the exist­ence of nation­al screen­ing, or VADS can­cers. For the lat­ter, cam­paigns could be run to explain, for example, that you should con­sult a doc­tor if you have a lesion in your mouth that hasn’t healed in three weeks”, explains Aurore Lor­etti. And in fact, accord­ing to OECD 2023 fig­ures, the budget spent by France on pre­ven­tion is well below the European aver­age5.

Post-dia­gnos­is, oth­er dif­fi­culties com­plic­ate the con­tinu­ation of care. In 2020, the num­ber of doc­tors per cap­ita in France was well below the EU aver­age (3.2 per 1,000 inhab­it­ants com­pared with 4 in Europe). While this short­age affects the pop­u­la­tion as a whole, it seems to have more adverse effects on dis­ad­vant­aged people, with longer delays in access­ing care in par­tic­u­lar, as sug­ges­ted by the 2014 VICAN2 sur­vey. How­ever, between 2017 and 2022, the num­ber of onco­lo­gists increased by 30% and the num­ber of radio­ther­ap­ists by 8%6.

Mater­i­al liv­ing con­di­tions also have an impact on patients’ decisions and on the treat­ment options avail­able to them. “Some patients put off treat­ment because they can’t afford to take time off work; oth­ers post­pone treat­ment to allow time to organ­ise care for depend­ents, made more dif­fi­cult by pre­cari­ous fin­an­cial resources. On the oth­er hand, doc­tors some­times refrain from offer­ing major sur­gery to cer­tain patients who are isol­ated or in very pre­cari­ous situ­ations, because they fear that return­ing home will be too dif­fi­cult” adds Aurore Loretti.

Stud­ies also show that inequal­it­ies are more marked among men than women through­out the health care pro­cess, espe­cially when they are isol­ated. “The fact of being a woman, or hav­ing women in one’s imme­di­ate circle, com­pensates in part for social status. Women are more famil­i­ar with the idea of care because they are often in charge of the family’s health and have benefited from reg­u­lar check-ups in the event of preg­nancy,” com­ments Aurore Lor­etti. Recent data7 shows, how­ever, that while the (sig­ni­fic­ant) inequal­it­ies in mor­tal­ity observed among men are tend­ing to dimin­ish, they are increas­ing among women. “Here again, the primary cause is tobacco con­sump­tion, which has ris­en sharply among women, par­tic­u­larly from dis­ad­vant­aged back­grounds, since the 1970s,” adds Gwenn Menvielle.

After the disease, an impact on quality of life

Few stud­ies look at the post-treat­ment peri­od, but those that do show that social inequal­it­ies con­tin­ue to play an import­ant role once treat­ment has been com­pleted. Lung can­cer, for example, is par­tic­u­larly impacted by social factors, lead­ing to great­er social inequal­it­ies and great­er uncer­tainty when it comes to return­ing to work8.

In a recent study9, Gwenn Men­vi­elle and her col­leagues looked at the after­math of breast can­cer. The team fol­lowed nearly 6,000 patients over a 2‑year peri­od and assessed their qual­ity of life using a score based on sev­er­al cri­ter­ia (fatigue, gen­er­al and psy­cho­lo­gic­al state, sexu­al health, side effects). At dia­gnos­is, the dif­fer­ences in qual­ity of life between the two socio-eco­nom­ic extremes, eval­u­ated at 6.7, were already sig­ni­fic­ant. They increased sig­ni­fic­antly over the course of the dis­ease (score of 11) and remained at a high­er level than at dia­gnos­is once treat­ment had been com­pleted (score of 10). 

For Gwenn Men­vi­elle, “the reas­ons for these dif­fer­ences are not to be found in the treat­ment, which was sim­il­ar for all the women. They prob­ably come from the sup­port ele­ments around the med­ic­al treat­ment: the fam­ily envir­on­ment likely to provide help on a daily basis, and the mater­i­al and fin­an­cial capa­city to fol­low care that extends bey­ond the purely cur­at­ive, such as psy­cho­ther­apy or physio­ther­apy ses­sions.” The research­er is now work­ing on a more detailed ana­lys­is of the impact of these factors.

Anne Orliac
1Cyrille Del­pi­erre, Sébas­tien Lamy, Pas­cale Gro­sclaude, Inégal­ités sociales face aux can­cers : du rôle du sys­tème de soins à l’incorporation bio­lo­gique de son environ­nement social ADSP n°94, mars 2016 https://​www​.hcsp​.fr/​e​x​p​l​o​r​e​.​c​g​i​/​A​d​s​p​?​c​l​e​f=151
2https://​www​.insee​.fr/​f​r​/​s​t​a​t​i​s​t​i​q​u​e​s​/​7​6​6​6​9​0​7​?​s​o​m​m​a​i​r​e​=​7​6​66953
3DARES Focus n°34, Les expos­i­tions des salar­iés aux produits chimiques can­céro­gènes, juin 2023 citant l’enquête Sumer 2016–2017 https://​dares​.trav​ail​-emploi​.gouv​.fr/​p​u​b​l​i​c​a​t​i​o​n​/​l​e​s​-​e​x​p​o​s​i​t​i​o​n​s​-​d​e​s​-​s​a​l​a​r​i​e​s​-​a​u​x​-​p​r​o​d​u​i​t​s​-​c​h​i​m​i​q​u​e​s​-​c​a​n​c​e​r​o​genes
4OCDE, Pro­fils sur le can­cer par pays : France 2023, Édi­tions OCDE, Par­is, https://​doi​.org/​1​0​.​1​7​8​7​/​1​d​d​7​d​d​7f-fr.
5OCDE, Pro­fils sur le can­cer par pays : France 2023, Édi­tions OCDE, Par­is, https://​doi​.org/​1​0​.​1​7​8​7​/​1​d​d​7​d​d​7f-fr.
6id.
7https://​www​.ineg​al​ites​.fr/​i​n​e​g​a​l​i​t​e​s​-​e​s​p​e​r​a​n​c​e​s​-​d​e​-​v​i​e​-​s​e​l​o​n​-​c​a​t​e​g​o​r​i​e​-​s​o​c​i​a​l​e​-​e​t​-sexe
8C. Chou­aïd & al. Déter­min­ants soci­aux et can­cer du pou­mon Social determ­in­ants and lung can­cer, https://​www​.sci​en​ce​dir​ect​.com/​s​c​i​e​n​c​e​/​a​r​t​i​c​l​e​/​a​b​s​/​p​i​i​/​S​1​8​7​7​1​2​0​3​1​7​3​00654, Revue des mal­ad­ies res­pir­atoires actu­al­ités, vol. 9 issue 2, septembre 2017, p. 332–337
9José Luis San­dov­al, Gwenn Men­vi­elle & al. Mag­nitude and Tem­por­al Vari­ations of Socioeco­nom­ic Inequal­it­ies in the Qual­ity of Life After Early Breast Can­cer: Res­ults From the Mul­ti­centric French CANTO Cohort, Journ­al of Clin­ic­al Onco­logy vol. 42, n°24, juin 2024 https://​doi​.org/​1​0​.​1​2​0​0​/​J​C​O​.​2​3.020

Support accurate information rooted in the scientific method.

Donate